Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on IT Press Releases.
Press releases published on May 2, 2025

Theratechnologies présente à la conférence ACTHIV 2025 de nouvelles données soulignant l’importance de prendre en charge l’excès de graisse viscérale abdominale chez les personnes vivant avec le VIH
L’analyse réalisée dans le cadre de l’étude VAMOS met en évidence le lien entre l’excès de graisse viscérale abdominale et la diminution de la qualité musculaire Selon ce qu’on rapporte dans la série de cas, l’association de la tésamoréline à un agoniste …

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, May 02, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that on May 1, …

Cartesian Therapeutics Announces New Employment Inducement Grants
FREDERICK, Md., May 02, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering cell therapy for the treatment of autoimmune diseases, today announced the granting of …

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
RESEARCH TRIANGLE PARK, N.C., May 02, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted seven newly-hired employees restricted stock units (RSUs) …

Aya Gold & Silver Provides Notice of First Quarter 2025 Results and Conference Call
MONTREAL, May 02, 2025 (GLOBE NEWSWIRE) -- Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation”) plans to release its first quarter 2025 results on Tuesday, May 13, 2025 before market opens. Senior management will host a conference …

Aya Or & Argent annonce la date de diffusion de ses résultats du premier trimestre de 2025 et de sa conférence téléphonique
MONTRÉAL, 02 mai 2025 (GLOBE NEWSWIRE) -- Aya Or & Argent Inc. (TSX : AYA; OTCQX : AYASF) (« Aya » ou la « Société ») prévoit publier ses résultats du premier trimestre de 2025 le mardi 13 mai 2025, avant l’ouverture des marchés. La haute direction tiendra …

Agios to Present at the BofA Securities 2025 Health Care Conference on May 14, 2025
CAMBRIDGE, Mass., May 02, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced that its management team is scheduled to present at the …

Metagenomi to Present at Upcoming Scientific Meetings
EMERYVILLE, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary gene editing toolbox, today announced that the …

Perella Weinberg Reports First Quarter 2025 Results
Financial Overview Revenues of $212 Million, Up 107% From a Year Ago Adjusted Pre-Tax Income of $21 Million, GAAP Pre-Tax Income of $12 Million Adjusted EPS of $0.28; GAAP Diluted EPS of $0.24 Talent Investment Year-to-Date Added Four Managing Directors …

VEON to release 1Q 2025 trading update on May 15, 2025
VEON to release 1Q 2025 trading update on May 15, 2025 Dubai, May 2, 2025 – VEON Ltd. (NASDAQ: VEON), a global digital operator, today confirms that the Group will release its selected financial and operating results for the first quarter ended March 31, …

Best Email Service For Business (2025): Klaviyo Awarded Top Email Marketing Software by Software Experts
NEW YORK CITY, May 02, 2025 (GLOBE NEWSWIRE) -- Software Experts has named Klaviyo one of the top email marketing platforms of the year. Klaviyo’s AI-powered automation, real-time customer data integration, and multi-channel marketing capabilities position …

Chengdu Origen and Vanotech Announce First Patient Dosed in VAN-2401 Phase 1 Trial of Gene Therapy for Wet Age-Related Macular Degeneration
Clinical trial of KH658 evaluates single suprachoroidal space administration of gene-therapy treatment for wet AMD CHENGDU, China and ROCKAWAY, N.J., May 02, 2025 (GLOBE NEWSWIRE) -- Chengdu Origen Biotechnology Co., Ltd. (“Chengdu Origen”) and Vanotech …

Orion Corporation: Managers’ transactions – Veli-Matti Mattila
ORION CORPORATION MANAGERS’ TRANSACTIONS 2 MAY 2025 at 11.45 EEST Orion Corporation: Managers’ transactions – Veli-Matti Mattila Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding …

Orion Oyj: Johtohenkilöiden liiketoimet – Veli-Matti Mattila
ORION OYJ JOHTOHENKILÖIDEN LIIKETOIMET 2.5.2025 KLO 11.45 Orion Oyj: Johtohenkilöiden liiketoimet – Veli-Matti Mattila Orion Oyj on saanut seuraavan Markkinoiden väärinkäyttöasetuksen (EU) N:o 596/2014 mukaisen ilmoituksen …

Orion Corporation: Managers’ transactions – Hilpi Rautelin
ORION CORPORATION MANAGERS’ TRANSACTIONS 2 MAY 2025 at 11.45 EEST Orion Corporation: Managers’ transactions – Hilpi Rautelin Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding …

Orion Oyj: Johtohenkilöiden liiketoimet – Hilpi Rautelin
ORION OYJ JOHTOHENKILÖIDEN LIIKETOIMET 2.5.2025 KLO 11.45 Orion Oyj: Johtohenkilöiden liiketoimet – Hilpi Rautelin Orion Oyj on saanut seuraavan Markkinoiden väärinkäyttöasetuksen (EU) N:o 596/2014 mukaisen ilmoituksen …

Orion Corporation: Managers’ transactions – Kari Jussi Aho
ORION CORPORATION MANAGERS’ TRANSACTIONS 2 MAY 2025 at 11.45 EEST Orion Corporation: Managers’ transactions – Kari Jussi Aho Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding …

Orion Oyj: Johtohenkilöiden liiketoimet – Kari Jussi Aho
ORION OYJ JOHTOHENKILÖIDEN LIIKETOIMET 2.5.2025 KLO 11.45 Orion Oyj: Johtohenkilöiden liiketoimet – Kari Jussi Aho Orion Oyj on saanut seuraavan Markkinoiden väärinkäyttöasetuksen (EU) N:o 596/2014 mukaisen ilmoituksen …

Orion Corporation: Managers’ transactions – Maziar Mike Doustdar
ORION CORPORATION MANAGERS’ TRANSACTIONS 2 MAY 2025 at 11.45 EEST Orion Corporation: Managers’ transactions – Maziar Mike Doustdar Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding …

Orion Oyj: Johtohenkilöiden liiketoimet – Maziar Mike Doustdar
ORION OYJ JOHTOHENKILÖIDEN LIIKETOIMET 2.5.2025 KLO 11.45 Orion Oyj: Johtohenkilöiden liiketoimet – Maziar Mike Doustdar Orion Oyj on saanut seuraavan Markkinoiden väärinkäyttöasetuksen (EU) N:o 596/2014 mukaisen ilmoituksen …